DOI: http://dx.doi.org/10.18203/2349-2902.isj20181125

Polygeline in patients with hypovolemia caused by accidental trauma: a prospective, multicentric, safety study

Sanjay Shah, Ajai Singh, Sanjay Kala, Rohita Shetty

Abstract


Background: Objective of present study was to evaluate the safety of polygeline (Haemaccel®) and its effect on vital sign parameters in patients with hypovolemia caused by accidental trauma.

Methods: Adverse drug reactions (ADRs) of polygeline within 6 hours after administration, and the effect of polygeline infusion on vital sign parameters, in trauma patients hospitalized at the emergency department, were evaluated in this prospective, multicentric, post-marketing observational study.

Results: One hundred forty patients (men: 81.4%; women: 18.6%), with a mean (±standard deviation) age of 33.7±10.6 years, were enrolled. At the time of admission, mean blood volume loss was 1400.1±558.8ml, with 86.4% patients reporting blood volume loss of >15%; 49.3% patients presented with class-II hypovolemia. No ADRs or any unusual clinically significant changes were reported within 6 hours of polygeline administration. All vital parameters (blood pressure and pulse rate) significantly improved at 1 hour of polygeline administration; this trend was sustained until 6 hours (p<0.001). Reduction in respiratory rate was significant at 1 and 6 hours versus baseline (p<0.001). Urine output and central venous oxygen saturation also showed significant improvement at 1 and 6 hours after treatment initiation (p<0.001). Arterial pH and mean blood lactate levels also showed a significant change from the baseline (p<0.05) at both 1 and 6 hours.

Conclusions: Polygeline was found to be safe and effective in improving hemodynamic stability in patients with hypovolemia due to accidental trauma.


Keywords


Colloids, Hemorrhage, Hypovolemia, Polygeline, Trauma

Full Text:

PDF

References


Road accidents in India decrease by 4.1% during 2016, fatalities rise by 3.2%. Press Information Bureau, Government of India, Ministry of Road Transport and Highways. Available at: http://pib.nic.in/newsite/PrintRelease.aspx?relid=170577. Accessed October 20, 2017.

Deane SA, Gaudry PL, Woods P. The management of injuries - a review of deaths in hospital. Aust N Z J Surg. 1988;58:463-9.

American Thoracic Society. Evidence-based colloid use in the critically ill: American Thoracic Society Consensus Statement. Am J Respir Crit Care Med. 2004;170:1247-59.

Brunkhorst FM, Engel C, Bloos F. German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125-39.

Myburgh JA, Finfer S, Bellomo R. CHEST Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367:1901-11.

Annane D, Siami S, Jaber S. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA. 2013;310:1809-17.

Bouglé A, Harrois A, Duranteau J. Resuscitative strategies in traumatic hemorrhagic shock. Ann Intensive Care. 2013;3:1.

Evans PA, Garnett M, Boffard K. Evaluation of the effect of colloid (Haemaccel) on the bleeding time in the trauma patient. J R Soc Med. 1996;89:101-4.

Hartog CS, Bauer M, Reinhart K. The efficacy and safety of colloid resuscitation in the critically ill. Anesth Analg. 2011;112:156-64.

Dippenaar JM, Naidoo S. Allergic reactions and anaphylaxis during anesthesia. Curr Allergy Clin Immunol. 2015;28:18-22.

Barron ME, Wilkes MM, Navickis RJ. A systematic review of the comparative safety of colloids. Arch Surg. 2004;139:552-63.

Cherkas D. Traumatic hemorrhagic shock: advances in fluid management. Emerg Med Pract. 2011;13:1-19.

Ahmad M, Adil N. Compatibility and stability of polygeline (Haemaccel) with different drug products. Pak J Pharm Sci. 2014;27:2227-35.

Rossaint R, Bouillon B, Cerny V. Task Force for Advanced Bleeding Care in Trauma. Management of bleeding following major trauma: an updated European guideline. Crit Care. 2010;14:R52.

Bunn F, Trivedi D. Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev. 2012;7:CD001319.

Mitra S, Khandelwal P. Are all colloids same? How to select the right colloid? Indian J Anaesth. 2009;53:592-607.

Adis International. Anaphylactic reaction to Haemaccel (infusion of polymerisate of peptides). Bulletin from SADRAC. 1990;57(4):1-2.

Davies MJ. The role of colloids in blood conservation. Int Anesthesiol Clin. 1990;28:205-9.

Wisborg K. Letter: Anaphylactic reactions induced by infusion of polygeline (haemaccel). Br J Anaesth. 1975;47:1116-7.

Vervloet D, Senft M, Dugue P. Anaphylactic reactions to modified fluid gelatins. J Allergy Clin Immunol. 1983;71:535-40.

Pepys J, Pepys EO, Baldo BA. Anaphylatic/ anaphylactoid reactions to anaesthetic and associated agents. Skin prick tests in aetiological. Anaesthesia. 1994;49:470-5.

Doenicke A, Ennis M, Lorenz W. Histamine release in anesthesia and surgery: a systematic approach to risk in the perioperative period. Int Anesthesiol Clin. 1985;23:41-66.

Weis KH. Haemaccel 35: adverse reactions in a multicentric, prospective study. Anaesthesist. 1983;32:488-93.

Singh A, Ali S. Polygeline in hypovolemia due to traumatic injury: Results of an open label study in Indian population. Int J Crit Illn Inj Sci. 2016;6:21-4.

Singh A, Ali S, Shetty R. Effectiveness and safety of polygeline in patients with hypovolemia due to trauma. J Emerg Trauma Shock. 2017;10:116-20.

Van der Linden P, Ickx BE. The effects of colloid solutions on hemostasis. Can J Anaesth. 2006;53:S30-9.

Orgev B. A trial of a plasma volume expander (haemaccel) in shock. S Afr Med J. 1969;43:1554-6.

Verma RK, Mishra LD, Nath S. Efficacy of polygeline preloading in prevention of hypotension following CSEA. Indian J Anaesth. 2005;49:105-8.

Boldt J. Fluid choice for resuscitation of the trauma patient: a review of the physiological, pharmacological, and clinical evidence. Can J Anaesth. 2004;51:500-513.

Köhler H, Kirch W, Fuchs P. Elimination of hexamethylene diisocyanate cross-linked polypeptides in patients with normal or impaired renal function. Eur J Clin Pharmacol. 1978;14:405-12.

Kaur P, Basu S, Kaur G. Transfusion protocol in trauma. J Emerg Trauma Shock. 2011;4:103-8.

Saddler JM, Horsey PJ. The new generation gelatins. A review of their history, manufacture and properties. Anaesthesia. 1987;42:998-1004.

Cotton BA, Guy JS, Morris JA Jr, et al. The cellular, metabolic, and systemic consequences of aggressive fluid resuscitation strategies.Shock. 2006;26:115-21.